Sign in

Ali Abdul-Sater

@aabdulsater.bsky.social
108 followers 154 following 26 posts

Immunologist. Associate Professor and Research Chair at York University, Toronto, Canada. We study inflammation in autoimmune rheumatic diseases

PostsRepliesMedia
Ali Abdul-Sater @aabdulsater.bsky.social · 29/05/2026
Our new study in collaboration with @jliggio.bsky.social and Samar Moussa from Environment and Climate Change Canada is out. phys.org/news/2026-05...
phys.org
New study shows atmospheric compounds formed from tire wear may pose human health risk
Tire rubber contains antioxidant chemicals, most notably 6PPD and DPPD, that are released into the air as tiny particles during normal driving. A single compound formed from 6PPD, known as 6PPD-quinon...
011
Reposted by Ali Abdul-Sater
Samar Moussa @samarmoussa.bsky.social · 29/05/2026
Excited to share our new study in Environment International showing that tire chemicals transform in the atmosphere into complex mixtures that trigger inflammation in human immune cells. Grateful to co-leads @jliggio.bsky.social @aabdulsater.bsky.social!! www.sciencedirect.com/science/arti...
sciencedirect.com
Atmospheric aging of tire rubber antioxidants forms complex mixtures that trigger inflammation in human macrophages
Antioxidants added to tires to prevent degradation have recently been recognized as emerging environmental contaminants. While their acute aquatic tox…
132
Reposted by Ali Abdul-Sater
Rodney DeKoter @rdekoter.bsky.social · 19/05/2026
Looking forward to Immune Synapses Toronto on May 28! Come join us to hear about some exciting immunology research. www.yorku.ca/events/immun...
yorku.ca
IMMUNE SYNAPSES TORONTO - Immune Synapses Toronto
Join us on May 28, 2026 The members of the organizing committee and the immunology community at YorkUniversity are pleased to welcome you to Immune Synapses Toronto, York University’sfirst immunology-...
032
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
We are hiring: ASSISTANT RESEARCH SCIENTIST AT THE PSA CARE HUB AT YORK UNIVERSITY
000
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
We are hiring: ASSOCIATE RESEARCH SCIENTIST AT THE PSA CARE HUB AT YORK UNIVERSITY
000
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
#PsACAREHub #PsoriaticArthritis #AutoimmuneResearch #Immunology #AcademicHiring #ScienceJobs #Rheumatology
001
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
📢 Help us spread the word! Like, share, and tag potential candidates who may be interested in joining the PsA CARE Hub. Together, we can drive innovation and improve outcomes for people living with PsA.
100
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
🔍 We're Hiring! We will soon be recruiting Associate and Assistant Research Scientists to join this groundbreaking initiative. If you're a scientist passionate about inflammation, immunology, or any field that can be applied to PsA research, stay tuned for opportunities!
100
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
focused on unraveling the cellular and molecular mechanisms driving PsA. By providing mentorship, cutting-edge resources, and a collaborative research environment, the Hub will empower the next generation of researchers to establish independent programs dedicated to PsA discovery.
100
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
PsA remains an underexplored disease at the mechanistic level, limiting the development of innovative treatments. The PsA CARE Hub, based at @YorkUniversity and funded by the @KrembilF, will address this critical gap by recruiting and supporting early-career scientists
100
Ali Abdul-Sater @aabdulsater.bsky.social · 12/02/2025
🚨 Exciting Announcement! We are thrilled to launch the Psoriatic Arthritis Collaborative and Applied Research Excellence (PsA CARE) Hub, the first research initiative in Canada dedicated to advancing the basic science of psoriatic arthritis (PsA).
122
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
Curious about the details? Check out the full paper here: www.sciencedirect.com/science/arti... Big shoutout to our amazing team and BIG thanks to the funding agencies that supported this work! CIHR, Arthritis Society of Canada and Banting Research Foundation
000
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
Next steps? Targeting TRAF1/cIAP2 interaction with small molecules or biologics! Could this be the next generation of RA therapy? Let’s find out.
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
Unlike current RA therapies that block cytokines, our approach prevents inflammation at its source—without broad immune suppression. This could help patients who don’t respond to existing treatments!
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
✅ Protected against LPS-induced septic shock ✅ Significantly reduced joint inflammation & disease severity in an RA model This suggests that disrupting TRAF1/cIAP2 signaling lowers inflammation without shutting down immunity!
110
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
🟩 The V203A mutation blocks TRAF1’s interaction with cIAP2. 🟩This shuts down TRAF1’s ability to amplify TLR4-driven inflammation. 🟩As a result, inflammatory cytokine production is significantly reduced.
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
We asked: Can we selectively disrupt TRAF1’s inflammatory function while keeping its protective role intact? Using CRISPR gene editing, we identified a mutation (V203A in humans, V196A in mice) that does just that!
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
TRAF1 is an immune signaling adapter linked to RA risk. It has a paradoxical role: it can both promote and suppress NF-κB & MAPK signaling. This complexity has made it hard to target therapeutically.
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
#RA is an autoimmune disease where chronic inflammation leads to joint damage. Current treatments target inflammatory cytokines, but many patients don’t respond or develop resistance. We need new approaches!
100
Ali Abdul-Sater @aabdulsater.bsky.social · 05/02/2025
Excited to share our latest study on #RheumatoidArthritis (RA) in Journal of Autoimmunity! We identified a critical mutation in TRAF1 that selectively reduces inflammation—offering a promising new therapeutic strategy. www.sciencedirect.com/science/arti...
sciencedirect.com
Selective disruption of Traf1/cIAP2 interaction attenuates inflammatory responses and rheumatoid arthritis
Tumor necrosis factor receptor-associated factor 1 (TRAF1) is an immune signaling adapter protein linked to increased susceptibility to rheumatoid art…
130
Reposted by Ali Abdul-Sater
Paola A. Marignani @pmarignani.bsky.social · 29/12/2024
Please share with your network. We are migrating Canadian Women in STEM to Bluesky from the other site. Our new website is up and running. Please Join and follow @cdnwomenstem.bsky.social
055
Ali Abdul-Sater @aabdulsater.bsky.social · 25/12/2024
Happy holidays from the Abdul-Sater lab ♥️♥️
000
Ali Abdul-Sater @aabdulsater.bsky.social · 08/12/2024
"reviewer 1" had a page and a half of comments 🙂
000
Ali Abdul-Sater @aabdulsater.bsky.social · 08/12/2024
I don't know why "Reviewer 2" gets a bad rap. We got the reviews back on a new submission and here's Rev 2's comments: "Reviewer #2: The results are persuasive, and the argument is straightforward. I did not find any major problems."
110
Ali Abdul-Sater @aabdulsater.bsky.social · 02/12/2024
Deal!
000
Ali Abdul-Sater @aabdulsater.bsky.social · 01/12/2024
Would be nice if made available on zoom 🙂
100
Ali Abdul-Sater @aabdulsater.bsky.social · 01/12/2024
Welcome to bsky @chrisperrymito.bsky.social 💪
020
Ali Abdul-Sater @aabdulsater.bsky.social · 22/11/2024
Congrats, Sunny! Great work
110
Reposted by Ali Abdul-Sater
Dr. Dawn Bowdish @msmacrophage.bsky.social · 22/11/2024
I spoke to the CBC Radio about a large measles outbreak in New Brunswick - article link below. I cannot stress enough how serious an infection measles is - recycling an op-ed I wrote on the topic(see link on my webpage for explainer video). www.cbc.ca/news/canada/... www.bowdish.ca/lab/2024/03/...
Image of a Globe & Mail op-ed on measles. For an accessible read see http://www.bowdish.ca/lab/2024/03/07/measles-is-not-a-harmless-childhood-infection-dr-bowdish-explains/
06438
Ali Abdul-Sater @aabdulsater.bsky.social · 22/11/2024
Here are my first impressions after using this platform for a few days: Bluesky is like Twitter if it went on a detox—no hate, no fake news, just good vibes and civilized conversations 😀
020